 |
|
|
Patient Monitoring & Connectivity 
Anesthesia Delivery & Ventilation 
Diagnostic Cardiology 
Clinician Education 
Top MDBuyline Scores for Spacelabs Telemetry
Tuesday, January 19, 2010
For immediate release
Spacelabs Healthcare's Telemetry Monitors Ranked Highest
In MD Buyline User Satisfaction Survey
Issaquah, Wash., January 18, 2010 – Spacelabs Healthcare, a leading manufacturer of patient monitoring and connectivity solutions, as well as diagnostic cardiology and anesthesia devices, has announced that it is ranked highest in telemetry monitoring according to MD Buyline’s most recent User Satisfaction Composite Ratings.
In this independent survey, Spacelabs telemetry users provided the highest overall ratings compared with scores from users of eight competing telemetry suppliers. In addition, Spacelabs telemetry scored highest in System Reliability as well as Service Repair Quality.
“It is gratifying to know that Spacelabs telemetry users realize the inherent quality of our products as well as our extraordinary efforts to provide them with only the best service experiences. We are grateful for their confidence in our people and our technology – and tremendously proud to receive this most recent recognition”, said Joe Davin, Group President at Spacelabs Healthcare.
Telemetry got its start in 1958 when NASA turned to Spacelabs to meet the ultimate clinical challenge – wireless monitoring of Gemini astronauts’ vital signs. Following this achievement, Spacelabs was the first to introduce telemetry to hospitals, and today hospitals around the world depend on Spacelabs for continuous, reliable monitoring of ambulatory patients.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the evaluation of the Company’s telemetry devices. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.